475 reports of this reaction
3.4% of all TETRABENAZINE reports
#4 most reported adverse reaction
DEPRESSION is the #4 most commonly reported adverse reaction for TETRABENAZINE, manufactured by Lundbeck Pharmaceuticals LLC. There are 475 FDA adverse event reports linking TETRABENAZINE to DEPRESSION. This represents approximately 3.4% of all 13,933 adverse event reports for this drug.
Patients taking TETRABENAZINE who experience depression should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEPRESSION is moderately reported among TETRABENAZINE users, representing a notable but not dominant share of adverse events.
In addition to depression, the following adverse reactions have been reported for TETRABENAZINE:
The following drugs have also been linked to depression in FDA adverse event reports:
DEPRESSION has been reported as an adverse event in 475 FDA reports for TETRABENAZINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEPRESSION accounts for approximately 3.4% of all adverse event reports for TETRABENAZINE, making it a notable side effect.
If you experience depression while taking TETRABENAZINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.